Yumiao Chen
Articles
-
Oct 18, 2023 |
onlinelibrary.wiley.com | Yumiao Chen |Wei Li |Zhongqiu Wang |Yingying Yu
Immune cells are pivotal in cancer immunotherapy, yet their therapeutic effectiveness is often hampered by limited tumor infiltration and inhibitory tumor microenvironments. We here introduce an alkaline phosphatase (ALP)-responsive and transformable supramolecular bis-specific cell engager (Supra-BiCE) to harness NK/T cells for effective cancer immunotherapy.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →